Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
Official title: French African Pediatric Oncology Registry
Run by French Africa Pediatric Oncology Group · NCT03803735 · Data updated 2026-11-12
This study is collecting information about children with cancer in French-speaking Africa to help improve cancer care and treatment programs for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Day to 18 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | French Africa Pediatric Oncology Group Academic / other |
| Locations | 14 sites (Ouagadougou and 13 other locations) |
| Status | Recruiting |
| Started | January 1, 2016 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | October 3, 2025 |
| Trial ID | NCT03803735 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are children and adolescents under 18 years of age who are presenting for treatment of any type of cancer.
✕Probably not a fit
Patients who do not have cancer or are over the age of 18 will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to collect detailed information about children diagnosed with cancer in pediatric oncology units across French-speaking Africa. It gathers data on demographics, socioeconomic status, clinical status, treatment outcomes, and vital status. The information will be entered online using the Research Electronic Data Capture (REDCap) program and will assist local and national health authorities in planning effective pediatric cancer programs.
Why it matters
Potential benefit: If successful, this registry could significantly improve pediatric cancer treatment and care in French-speaking Africa by providing essential data for healthcare planning.
How similar studies have gone: While this approach is not widely tested, similar registries have shown success in improving cancer care by providing critical data for treatment planning.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Any child presenting at any one of the participating units for treatment 2. Any child with any type of cancer 3. Any child or adolescent less than 18 years of age. Exclusion Criteria: 1. No cancer found 2. Age greater than 18 years -
Where it's running
-
Hopital Yalgado Ouedraogo
Ouagadougou, Burkina Faso Recruiting -
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, Burkina Faso Recruiting -
Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)
Yaoundé, Cameroon Recruiting -
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District, Côte d’Ivoire Recruiting -
Cliniques Universitaires de Kinshasa
Kinshasa, Kinshasa City, Democratic Republic of the Congo Recruiting -
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, Democratic Republic of the Congo Recruiting
Show 8 more locations
-
Gfaop
Villejuif, Paris, France Recruiting -
l'Institut de Cancérologie de Libreville
Libreville, Gabon Recruiting -
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Ampefiloha, Madagascar Recruiting -
CHU Gabriel Touré (HGT)
Bamako, Mali Recruiting -
Centre National d'Oncologie (CNO)
Nouakchott, Mauritania Recruiting -
CNLC, Centre National de Lutte contre le Cancer
Niamey, Niger Recruiting -
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Dakar, Senegal Recruiting -
CHU Sylvanus Olympio
Lomé, Togo Recruiting
Study contacts
- Study coordinator: Brenda MALLON, MSC
- Email: brenda.mallon@gustaveroussy.fr
- Phone: + 33142115411
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.